GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Infant Bacterial Therapeutics AB (OSTO:IBT B) » Definitions » FCF Yield %

Infant Bacterial Therapeutics AB (OSTO:IBT B) FCF Yield % : -22.88 (As of Oct. 31, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Infant Bacterial Therapeutics AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Infant Bacterial Therapeutics AB's Trailing 12-Month Free Cash Flow is kr-120.80 Mil, and Market Cap is kr528.08 Mil. Therefore, Infant Bacterial Therapeutics AB's FCF Yield % for today is -22.88%.

The historical rank and industry rank for Infant Bacterial Therapeutics AB's FCF Yield % or its related term are showing as below:

OSTO:IBT B' s FCF Yield % Range Over the Past 10 Years
Min: -24.5   Med: -4.05   Max: -1.37
Current: -22.88


During the past 10 years, the highest FCF Yield % of Infant Bacterial Therapeutics AB was -1.37%. The lowest was -24.50%. And the median was -4.05%.

OSTO:IBT B's FCF Yield % is ranked worse than
62.26% of 1513 companies
in the Biotechnology industry
Industry Median: -12.69 vs OSTO:IBT B: -22.88

Infant Bacterial Therapeutics AB's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.


Infant Bacterial Therapeutics AB FCF Yield % Historical Data

The historical data trend for Infant Bacterial Therapeutics AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infant Bacterial Therapeutics AB FCF Yield % Chart

Infant Bacterial Therapeutics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.20 -4.64 -7.42 -15.28 -8.35

Infant Bacterial Therapeutics AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.88 -11.13 -9.49 -9.19 -11.62

Competitive Comparison of Infant Bacterial Therapeutics AB's FCF Yield %

For the Biotechnology subindustry, Infant Bacterial Therapeutics AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infant Bacterial Therapeutics AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Infant Bacterial Therapeutics AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Infant Bacterial Therapeutics AB's FCF Yield % falls into.



Infant Bacterial Therapeutics AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Infant Bacterial Therapeutics AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-101.219 / 1212.426
=-8.35%

Infant Bacterial Therapeutics AB's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-37.972 * 4 / 1306.7258
=-11.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Infant Bacterial Therapeutics AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Infant Bacterial Therapeutics AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Infant Bacterial Therapeutics AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Infant Bacterial Therapeutics AB Business Description

Traded in Other Exchanges
Address
Bryggargatan 10, Stockholm, SWE, 111 21
Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a reduced incidence of necrotizing enterocolitis (NEC) and improved gastrointestinal function (SFT) when treated with IBP-9414's active substance Lactobacillus reuteri bacterial strain naturally found in human breast milk. Its portfolio also includes additional drug candidates, IBP-1016, IBP-1118 and IBP-1122. IBP1016, for the treatment of gastroschisis, is a life-threatening and rare disorder in which children are born with externalized gastrointestinal organs.

Infant Bacterial Therapeutics AB Headlines

No Headlines